Pharmaceutical composition comprising Anti-DLL3 antibody-drug conjugate
TW202626109APending Publication Date: 2026-07-01SUZHOU SUNCADIA BIOPHARM CO LTD +2
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- TW114132767
- Authority / Receiving Office
- TW · TW
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2024-08-27
- Filing Date
- 2025-08-27
- Publication Date
- 2026-07-01
Abstract
The present disclosure relates to a pharmaceutical composition comprising an anti-DLL3 antibody-drug conjugate. Specifically, the present disclosure relates to the use of the pharmaceutical composition comprising anti-DLL3 antibody-drug conjugates in preparing a medicament for the treatment or prevention of a disease.
Need to check novelty before this filing date? Find Prior Art